Ebola Virus Disease (EVD) remains one of the world’s most severe and deadly public health threats, characterized by high case fatality rates, rapid transmission through direct contact with infected bodily fluids, and significant social and economic disruption. Since its discovery in 1976 in what is now the Democratic Republic of the Congo (DRC), Ebola outbreaks have periodically occurred across Central and West Africa, requiring coordinated national, regional, and global response efforts. (CDC)
The current Ebola outbreak, caused by the Bundibugyo virus species, was first identified in May 2026 following a cluster of severe illnesses among healthcare workers in Bunia Health Zone in northeastern DRC. Subsequent laboratory investigations confirmed Bundibugyo virus infection, marking the latest cross-border Ebola outbreak affecting both the DRC and Uganda. As of early June 2026, hundreds of confirmed cases and deaths have been reported across affected areas, prompting an intensified response from national governments, regional institutions, and international partners. (CDC)
Unlike outbreaks caused by the Zaire strain of Ebola virus, there is currently no licensed vaccine specifically approved for the Bundibugyo virus. Consequently, outbreak control relies heavily on early detection, case management, infection prevention and control measures, laboratory surveillance, contact tracing, risk communication, community engagement, and cross-border coordination. (CDC)